Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Ending Cash Position : $2,003 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Ending Cash Position?

Takeda Pharmaceutical Co's Ending Cash Position for the quarter that ended in Dec. 2023 was $2,003 Mil.

Takeda Pharmaceutical Co's quarterly Ending Cash Position declined from Jun. 2023 ($2,238 Mil) to Sep. 2023 ($2,151 Mil) and declined from Sep. 2023 ($2,151 Mil) to Dec. 2023 ($2,003 Mil).

Takeda Pharmaceutical Co's annual Ending Cash Position declined from Mar. 2021 ($8,889 Mil) to Mar. 2022 ($7,166 Mil) and declined from Mar. 2022 ($7,166 Mil) to Mar. 2023 ($3,992 Mil).

Takeda Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Takeda Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Ending Cash Position Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Ending Cash Position

Get a 7-Day Free Trial

6,316.95

5,922.08

8,888.96

7,165.74

3,991.57

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															5,078.32	3,991.57	2,238.15	2,151.25	2,002.75

Takeda Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Takeda Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6356.934	+	-2365.367
	=	3,992

Takeda Pharmaceutical Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2208.978	+	-206.228
	=	2,003

Takeda Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.